Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine - 1 Sept 2016

Singh Dave, Roche Nicolas, Halpin David, Agusti Alvar, Wedzicha Jadwiga A, Martinez Fernando J

Abstract excerpt

Clinical phenotyping is currently used to guide pharmacological treatment decisions in chronic obstructive pulmonary disease (COPD), a personalized approach to care. Precision medicine integrates biological (endotype) and clinical (phenotype) information for a more individualized approach to pharmacotherapy, to maximize the benefit versus risk ratio. Biomarkers can be used to identify endotypes. To evolve toward...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Drug Therapy, Combination

Share to Phenotype

Share to Pulmonary Disease, Chronic Obstructive

Share to Risk Assessment

Share to Severity of Illness Index

Source

Identifiers

PMID: 27585383
DOI: 10.1164/rccm.201606-1179PP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.PMID 27585383Read ↗

Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping.Semantic proximity Read ↗

Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?Semantic proximity Read ↗

[PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].Semantic proximity Read ↗

Chronic obstructive pulmonary disease subpopulations and phenotyping.Semantic proximity Read ↗

Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management.Semantic proximity Read ↗

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1.Semantic proximity Read ↗

The Challenges of Precision Medicine in COPD.Semantic proximity Read ↗

Biomarkers for precision medicine in airways disease.Semantic proximity Read ↗

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.Semantic proximity Read ↗

Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits.Semantic proximity Read ↗

Defining phenotypes in COPD: an aid to personalized healthcare.Semantic proximity Read ↗

"Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art."Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.